During 2027, Digia will publish a financial statement bulletin, two business reviews and a half-year financial report as follows: The 2026 Board of Directors' Report and Financial Statements will be ...

Inside information: Wärtsilä sets new mid-term financial targets to accelerate value creation and moves to a new guidance practice in 2027 Wärtsilä Board of Directors has approved new financial ...

Finnair will hold a results press conference (in Finnish) on 27 October 2026 at 11:00 a.m. Finnish time (EET) at its office at Tietotie 9 in Vantaa, Finland. It is also possible to participate in the ...

“Vaisala had an excellent third quarter of 2026, with record high order intake, solid net sales growth, and very strong profitability. Industrial Measurements once again performed exceptionally, ...

Tieto expects its organic1) growth to be in the range of -6% to -5% (revenue in 2025: EUR 1 852.3 million). The company estimates its full-year adjusted operating margin2) (adjusted EBITA3)) to be ...

October 26, 2026 at 13:31:00 EET. Changes in Framery Group's organizational structure and Management Team To bolster the execution of ...

Apetit Group’s CEO Esa Mäki has resigned from his position. Mäki has committed to continuing in his position until the end of May 2027 and will serve as an adviser to the management until the end of ...

To accelerate the implementation of its strategy and support its next phase of growth, Orion Corporation (“Orion”) is adjusting the composition and responsibilities of its executive team as of 1 ...

Study met its primary objective: 1-year graft failure-free survival at 12 months post-transplant was 90%, which is clinically meaningful Graft and patient survival were 92% and 98%, respectively ...

MONACO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Around 100 yachting professionals gathered at the Yacht Club de Monaco on Thursday, 8 October, for the Winter Pop-Up organized by Cluster Yachting Monaco.

Remibrutinib achieved significant and clinically meaningful reduction in relapses vs. teriflunomide, to approximately 1 relapse every 13 years, without the need for chronic B-cell ...

Operating result was EUR 5.0 (3.2) million. EBITDA was EUR 7.4 (5.0) million. The net sales of Food Solutions were EUR 20.0 (19.0) million and operating result EUR 5.2 (2.7) million of which the net ...